Lawsuit for Investors in NASDAQ: TSRO shares against TESARO Inc announced by Shareholders Foundation

SAN DIEGO, Feb. 05, 2018 -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NASDAQ:TSRO shares over alleged Securities Laws Violations by TESARO Inc.

Investors, who purchased shares of TESARO Inc (NASDAQ:TSRO) in March 2016 or earlier and continue to hold any of those NASDAQ:TSRO shares, have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.

The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that substantial undisclosed health risks, including anaphylaxis and anaphylactic shock, were associated with Tesaro’s intravenous formulation of Varubi, and that as a result of the foregoing, Tesaro’s shares traded at artificially inflated prices between March 14, 2016 and January 12, 2018, and class members suffered significant losses and damages.

Those who purchased TESARO Inc (NASDAQ:TSRO) shares should contact the Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

CONTACT:
Shareholders Foundation, Inc. 
Michael Daniels 
+1 (858) 779-1554 
[email protected] 
3111 Camino Del Rio North 
Suite 423 
San Diego, CA 92108